Further experiments confirmed that GPC2 positively regulated PI3K/AKT signaling though MDK, and overexpression of MDK attenuated the inhibitory effect of GPC2 knockdown on malignant behaviors of prostate cancer. This evidence concerns the gene MDK and prostate carcinoma.